Document:

exv10w7wiii

 

Exhibit 10.7(iii)

	 	 	 
	

	 	TopSpin Medical (Israel) Ltd.

	 	 	 
	To:

	 	Date: April 6th, 2006

	Mr. Erez Golan, CEO
	 	 

Re: Amendment to Employment Agreement

Dear Sir,

	1.	 	Pursuant to Section 6.6 of your employment agreement with the TopSpin Medical (Israel)
Ltd. (the “Company”), dated as of December 9, 2002, as amended (the “Employment Agreement”;
all capitalized terms used herein and not otherwise defined herein shall have the meanings
ascribed to them in the Employment Agreement), you are entitled to a class C Company Car and
were provided with a Citroen C5 (the “Car”).
	 
	2.	 	As a result of the reclassification of the new Citroen C5 currently used by you, the Car
is now classified as a class D car.
	 
	3.	 	This letter is to inform you that in accordance with the resolution of the Board of
Directors of the Company, dated as of April 6th, 2006, Section 6.6 to the
Employment Agreement shall be amended such that the Company Car you shall be entitled to
under the Employment Agreement shall be a class D car, effective as of January 1, 2006.
	 
	4.	 	All other terms and conditions of the Employment Agreement not specifically amended
herein shall remain unchanged and in full force and effect.
	 
	5.	 	Please confirm your consent to the abovementioned by returning an executed copy of this
letter.

	 	 	 	 	 
	 
	 	 	 	 
	 

	 	 

TopSpin Medical (Israel) Ltd.
	 	 

I accept and confirm the above:

	 	 	 
	 
	 	 
	 

Erez Golan, CEOexv10w7wiv

 

Exhibit 10.7(iv)

	 	 	 
	

	 	TopSpin Medical (Israel) Ltd.

	 	 	 
	To:

	 	Date: January 7th, 2007

	Mr. Erez Golan
	 	 

Re: Amendment to Employment Agreement

Dear Sir,

We are pleased to inform you that on January 7, 2007 the stockholders of TopSpin Medical (Israel)
Ltd. (the “Company”) and the Board of Directors of the Company approved, following the
recommendation and the approval of the ESOP and Compensation Committee, the Audit Committee and
Board of Directors of TopSpin Medical, Inc., the Company’s parent company (the “Corporation”) on
November 17, 2007 and the approval of the stockholders of the Corporation on January 7, 2007, to
amend the terms of your employment with the Company in accordance with the following:

	1.	 	Salary: notwithstanding Section 5 of the Employment Agreement between you and the
Company, dated as of December 9, 2002, as amended (the “Employment Agreement”; all
capitalized terms used herein and not otherwise defined herein shall have the meanings
ascribed to them in the Employment Agreement), your monthly Salary shall be amended to a
total of NIS 55,000, to be linked to the increase of the Consumer Price Index (“CPI”) from
the CPI known on November 17, 2006 to the CPI as known on the date of payment of the Salary.
	 
	2.	 	Cash Bonus: you shall be entitled to receive a cash bonus to be calculated on the
basis of the Corporations revenues from sales of the Corporation’s IVMRI catheter system for
the cardiology field during the year 2007 (the “Revenues”), such cash bonus equaling 10% of
the Revenues grossed by the Corporation over US$ 250,000 and up to US$ 500,000 and 5% of the
Revenues grossed by the Corporation over US$ 500,000. The accumulated Revenues shall be
reviewed at the end of each calendar quarter of 2007. The cash bonus shall be calculated and
paid with respect to Revenues accumulated as of January 1, 2007 and until the end of each
quarter (after deduction of any amount paid on account of the cash bonus on the preceding
quarters). The cash bonus shall be paid with in 14 days following the approval of the
quarterly financial statements by the Board.
	 
	3.	 	Options: you shall be entitled to receive option to purchase Common Stock of the
Corporation with a par value of US$ 0.001 each, in the number and under the terms and
conditions set forth in the Option Agreement attached hereto as Exhibit A.
	 
	4.	 	All other terms and conditions of the Employment Agreement not specifically amended herein
shall remain unchanged and in full force and effect.
	 
	5.	 	Please confirm your consent to the abovementioned by returning an executed copy of this
letter.

	 	 	 	 	 
	 
	 	 	 	 
	 

	 	 

TopSpin Medical (Israel) Ltd.
	 	 

 

 

Agreed and confirmed:

	 	 	 
	 
	 	 
	 

TopSpin Medical, Inc.

	 	 

I confirm and agree to the above:

	 	 	 
	 
	 	 
	 

Erez Golanexv10w7wv

 

Exhibit 10.7(v)

Option Agreement

This option agreement (“Agreement”) is effective as of January 7, 2007 (the “Date of Grant”), by
and between Erez Golan (“Optionee”) and Topspin Medical, Inc. (the “Corporation”).

Under the Topspin Medical Inc. 2003 Israeli Stock Option Plan (“Plan”) (a copy of which is attached
hereto as Exhibit A), the Corporation hereby grants to the Optionee options to purchase such number
of shares of Common Stock of the Corporation par value US$0.001 each as set forth below (“Options”)
pursuant and subject to the terms and provisions set forth in the Plan and as provided herein.

All capitalized terms not otherwise defined herein shall have the meaning ascribed to them in the
Plan.

Notwithstanding any other provision of this Agreement or the Plan, it is hereby clarified that the
grant of Option pursuant to this Agreement is conditioned upon the approval of the Tel Aviv Stock
Exchange of the registration to trade of the shares of common stock of the Corporation into which
the Options are exercisable (the “Shares”), and the provisions of this Agreement and the Grant of
Stock to the Optionee will be entered into force and effect only after the Corporation provides
Optionee with written notice that the Tel Aviv Stock Exchange approved the registration to trade of
the Shares. If such approval will not be obtained until 60 days after the Date of Grant this
Agreement shall become null and void, and Optionee shall have no claim against the Corporation, its
affiliates or any of their directors, officers and shareholders with respect to the Options or the
underlying Shares.

	 	1.	 	Terms and Conditions of Options

	 	 	 
	Number of Options:
	 	2,400,000
	 
	 	Each Option shall be exercisable for one (1) share of
	 
	 	Common Stock of the Corporation par value  US$0.001
	 
	 	each.
	 
	 	 
	Exercise Price:
	 	$0.1503 per share.
	 
	 	 
	Type of Options:
	 	o Approved 102 Options:
	 
	 	          þ Capital Gain Options (CGO);
	 
	 	          o Ordinary Income Options (OIO)
	 
	 	o Unapproved 102 Options
	 
	 	o 3(9) Options

	 	 	 
	Vesting Schedule:
	 	All Options shall vest if and to the extent Optionee is
	 
	 	an employee of TopSpin Medical (Israel) Ltd.

 

 

	 	 	 	 	 	 	 
	 	 	(“TopSpin”) at the time of vesting. The Options shall

vest in accordance with the following schedule:
	 
	 	 	 	 	 	 
	 
	 	 	1.	 	 	600,000 Options shall vest upon receipt by the Corporation of the CE Mark approval
	 
	 	 	 	 	 	("CE Approval") for its IVMRI catheter system for the cardiology field
	 
	 	 	 	 	 	("Product"), if and to the extent the CE Approval with respect to such Product is
	 
	 	 	 	 	 	granted by December 31, 2006 or up to 3 months thereafter (i.e. March 31, 2007).
	 
	 	 	 	 	 	 
	 
	 	 	2.	 	 	960,000 Options shall vest upon receipt by the Corporation of the FDA market approval
	 
	 	 	 	 	 	or market clearance ("FDA Approval") to its Product, if and to
	 
	 	 	 	 	 	the extent the FDA Approval with respect to such Product is granted by June 30, 2007
	 
	 	 	 	 	 	or up to 4.5 months thereafter (i.e. November 15, 2007).
	 
	 	 	 	 	 	 
	 
	 	 	3.	 	 	840,000 Options shall vest upon the occurrence of the earlier of: (i) receiving a term
	 
	 	 	 	 	 	sheet for investment in TopSpin Urology Ltd., the Corporation's
	 
	 	 	 	 	 	fully owned subsidiary (the "Subsidiary") or in any other entity that holds or will hold the intellectual
	 
	 	 	 	 	 	property or rights in applications and/or implementation of the Corporation's intellectual
	 
	 	 	 	 	 	property rights and business in the urology field ("Urology Business") including raising funds by the
	 
	 	 	 	 	 	Corporation for the purpose of developing the Urology Business by November 30, 2007, in the gross amount of
	 
	 	 	 	 	 	not less than  US$1,000,000 and from investors which shall not include the grant of funds from the Israeli
	 
	 	 	 	 	 	Office of the Chief Scientist; (ii) the sale, transfer, grant of license or any other disposition of all or
	 
	 	 	 	 	 	substantially all of the Urology Business or signing a term sheet or any agreement in connection therewith by
	 
	 	 	 	 	 	November 30, 2007; or (iii) resolution in good faith by the Board of Directors of Corporation to internally
	 
	 	 	 	 	 	fund the Urology Business instead of pursuing reasonably available outside funding per the terms
	 
	 	 	 	 	 	above by November 30, 2007.

	2.	 	Exercise of Options

The exercise of the Options shall be by delivery by the Optionee to the Corporation at its
principle executive office of a written notice of exercise in the form attached hereto as
Exhibit B, specifying inter alia the number of shares of Stock to be purchased and
accompanied by the payment of the Exercise Price.

 

 

Options may be exercised only to purchase whole shares of Stock (the “Shares”), and in no
case may a fraction of a Share be purchased. If any fractional Share would be deliverable
upon exercise, such fraction shall be rounded up one-half or less, or otherwise rounded
down, to the nearest whole number.

The Corporation shall not be obligated to issue any Shares upon the exercise of an Option
if such issuance, in the opinion of the Corporation, might constitute a violation by the
Corporation of any provision of law.

	3.	 	Other Provisions

	 	3.1	 	All other terms and conditions, including terms and conditions of
expiration and termination of the Options, voting rights and adjustments, which are
set forth in the Plan, shall apply to the Options, provided however that in case of
any contradiction between the terms of the Options specified herein and the Plan, the
terms specified herein shall prevail. Notwithstanding anything to the contrary in the
Plan, and subject to Section 7.5(i) of the Plan, vested Options shall be exercisable
for a period of 1 year following the termination of all of the Corporation’s or any
of its subsidiaries’ engagements and relationship with the Optionee (whether as an
employee, consultant, director or otherwise).

Notwithstanding any other provision of this Agreement or the Plan, it is hereby
clarified the issuance of the Options and the Shares, their holding and transfer,
are subject to the provisions of any applicable law, including, without
limitation, the lock up periods imposed pursuant the provisions of the Securities
Law, 1968.

	 	3.2	 	Optionee acknowledges receipt of a copy of the Plan and represents that he
or she is familiar with the terms and provisions thereof, and hereby accepts this
Agreement subject to all of the terms and provisions thereof. Optionee has reviewed
the Plan and this Agreement in their entirety, has had an opportunity to obtain the
advice of counsel prior to executing this Agreement and fully understands all
provisions of the Agreement, the provisions of Sections 102 and 3(9) of the Israeli
Income Tax Ordinance [New Version] 1961 as amended and all rules, regulations and
orders promulgated thereunder and the tax route applicable to the Options granted to
him/her.
	 
	 	3.3	 	Optionee hereby agrees to accept as binding, conclusive and final all
decisions or interpretations of the Board or the Committee upon any question arising
under the Plan or this Agreement. Optionee further agrees to notify the Corporation
upon any change in the residence address indicated below.
	 
	 	3.4	 	Optionee hereby acknowledges and confirms that he agrees to be bound by all
terms and conditions of the trust agreements by and

 

 

among the Corporation, TopSpin Medical (Israel) Ltd. and the Trustee, copies of
which are attached hereto as Exhibit C.

	 	3.5	 	The Optionee shall regard the information in this Agreement and its
exhibits attached hereto as confidential information and the Optionee shall not
reveal their contents to anyone except when required by law or for the purpose of
gaining legal or tax advice.
	 
	 	3.6	 	Subject to the provisions of the Plan, to which this Agreement is subject,
this Agreement, together with the exhibits hereto, constitute the entire agreement
between the Optionee and the Corporation with respect to Options granted hereunder,
and supersedes all prior agreements, understandings and arrangements, oral or
written, between the Optionee and the Corporation with respect to the subject matter
hereof.
	 
	 	3.7	 	The Options provided for herein are granted pursuant to the Plan and said
Options and this Agreement are in all respects governed by the Plan and subject to
all of the terms and provisions of the Plan. Any interpretation of this Agreement
will be made in accordance with the Plan. In the event there is any contradiction
between the provisions of this Agreement and the Plan, the provisions of the Plan
will prevail.
	 
	 	3.8	 	The Plan and this Agreement shall be binding upon the heirs, executors,
administrators and successors of the parties hereof.
	 
	 	3.9	 	All notices or other communications given or made hereunder shall be in
writing and shall be delivered or mailed by registered mail or delivered by email or
facsimile with written confirmation of receipt to the Optionee and/or to the
Corporation at the addresses shown below, or at such other place as the Corporation
may designate by written notice to the Optionee.

IN WITNESS WHEREOF, the Parties hereto have executed this Agreement on the date first above
written.

	 	 	 	 	 	 	 
	 
	 	                                                            	 	                                                            	 	 
	 
	 	Optionee	 	Topspin Medical, Inc.	 	 
	 
	 	 	 	By:	 	 
	 
	 	 	 	 	 	 
	 
	 	Address:	 	 	 	 
	 
	 	                                                            	 	 	 	 
	 
	 	                                                            	 	 	 	 
	 
	 	                                                            	 	 	 	 

 

 

Exhibit A

The Plan

 

 

Exhibit B

Notice of Exercise

Exercise of Option The undersigned (the “Optionee”) hereby elects to exercise Optionee’s
Option to purchase                     shares of Common Stock par value US$ 0.001 each of TopSpin Medical,
Inc. (hereinafter the “Corporation” and the “Exercised Shares”) pursuant to the Topspin Medical,
Inc. 2003 Israeli Stock Option Plan (the “Plan”) and the Option Agreement dated                                         ,
(the “Option Agreement”).

All capitalized terms not otherwise defined herein shall have the meaning ascribed to them in the
Plan.

Delivery of Payment – Optionee herewith delivers to the Corporation the full Exercise Price
for the Exercised Shares, as set forth in the Option Agreement.

Representations of Optionee — Optionee acknowledges that Optionee has received, read and
understood the Plan, the Option Agreement and the trust agreements by and among the Corporation,
TopSpin Medical (Israel) Ltd. and the Trustee and agrees to abide by and be bound by their terms
and conditions. The Optionee further represents that in exercising the Option, the Optionee hereby
confirms and acknowledges that (i) the Exercised Shares are being acquired solely for the account
of the undersigned and not as a nominee for any other party, or for investment, and not with a view
to, or intention of, or otherwise for resale in connection with, any distribution; (ii) neither the
offer or sale of the Exercised Shares, nor the Exercised Shares themselves, have been registered
under the Securities Act of 1933, as amended, (the “Act”), or registered or qualified under the
applicable securities laws of any state or other jurisdiction, and that the Exercised Shares are
being sold to the Optionee by reason of and in reliance upon a specific exemption from the
registration provisions of the Act, and exemptions from registration or qualification provisions of
such applicable state or other jurisdiction securities laws which depend upon, among other things,
the bona fide nature of the investment intent as expressed herein and the truth and accuracy of the
representations and warranties of the Optionee set forth herein; and (iii) that the Optionee will
not offer, sell or otherwise dispose of the Exercised Shares except under circumstances that will
not result in a violation of the Act or any state securities laws and that the certificates
representing the Exercised Shares may bear a legend noting such restrictions.

Tax Consequences – Any tax consequences and/or future payment and/or costs arising from the
grant or exercise of any Option, from the payment for Shares covered thereby or from any other
event or act (of the Corporation and/or its Affiliates and the Trustee or the Optionee), hereunder,
shall be borne solely by the Optionee. The Corporation and/or its Affiliates, and/or the Trustee
shall withhold taxes according to the requirements under the applicable laws, rules, and
regulations, including the withholding of taxes at source. Furthermore, the Optionee shall agree to
indemnify the Corporation and/or its Affiliates and/or the Trustee and hold them harmless against
and from any and all liabilities for any such tax or interest or penalty thereon,

 

 

including without limitation, liabilities relating to the necessity to withhold, or to have
withheld, any such tax from any payment made to the Optionee.

Submitted on                                          by

OPTIONEE

                                                            

Signature

                                                            

Print Name

Address:                                         

 

 

Exhibit C

Trust Agreements

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00116-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00116-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00116-of-00352.parquet"}]]